{"title":"经导管主动脉瓣置入术中Navitor复位失败1例报告。","authors":"Hiroshi Onoda, Hiroshi Ueno, Yuki Hida, Teruhiko Imamura, Koichiro Kinugawa","doi":"10.1093/ehjcr/ytaf015","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Self-expanding valves used in transcatheter aortic valve implantation (TAVI) are designed to allow recapture and repositioning, facilitating optimal placement and mitigating conduction disturbances and paravalvular leakage. Here, we present a rare case in which the Navitor (Abbott Structural Heart, Santa Clara, CA, USA) could not be recaptured.</p><p><strong>Case summary: </strong>An 81-year-old Japanese woman with very severe aortic stenosis and a massively calcified nodule at the non-coronary cusp (NCC) underwent TAVI with a 25 mm Navitor valve. During the initial deployment attempt, non-uniform expansion (NUE) was observed on the NCC side when the valve was 80% deployed. An attempt was made to recapture and reposition the valve, but the delivery system capsule failed to fully re-sheath the prosthesis, leaving approximately one-third of the valve outside the capsule and preventing complete recapture. The Navitor was promptly redeployed while still within the basal ring. Following redeployment, the NUE resolved, and the valve was successfully positioned 3 mm below the basal ring on the NCC side and 4 mm below the left coronary cusp. We hypothesized that interference between the capsule tip and the calcified nodule on the NCC leaflet inhibited the re-sheathing process.</p><p><strong>Conclusion: </strong>This report documents a rare complication involving the failure to recapture the Navitor valve. In cases with large calcified nodules on the leaflet, caution is essential during the re-sheathing process. We strongly recommend re-deploying the prosthesis rather than attempting to remove it from the basal ring to minimize procedural risks and ensure proper valve placement.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"9 1","pages":"ytaf015"},"PeriodicalIF":0.8000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770386/pdf/","citationCount":"0","resultStr":"{\"title\":\"Re-sheathing failure with Navitor during transcatheter aortic valve implantation: a case report.\",\"authors\":\"Hiroshi Onoda, Hiroshi Ueno, Yuki Hida, Teruhiko Imamura, Koichiro Kinugawa\",\"doi\":\"10.1093/ehjcr/ytaf015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Self-expanding valves used in transcatheter aortic valve implantation (TAVI) are designed to allow recapture and repositioning, facilitating optimal placement and mitigating conduction disturbances and paravalvular leakage. Here, we present a rare case in which the Navitor (Abbott Structural Heart, Santa Clara, CA, USA) could not be recaptured.</p><p><strong>Case summary: </strong>An 81-year-old Japanese woman with very severe aortic stenosis and a massively calcified nodule at the non-coronary cusp (NCC) underwent TAVI with a 25 mm Navitor valve. During the initial deployment attempt, non-uniform expansion (NUE) was observed on the NCC side when the valve was 80% deployed. An attempt was made to recapture and reposition the valve, but the delivery system capsule failed to fully re-sheath the prosthesis, leaving approximately one-third of the valve outside the capsule and preventing complete recapture. The Navitor was promptly redeployed while still within the basal ring. Following redeployment, the NUE resolved, and the valve was successfully positioned 3 mm below the basal ring on the NCC side and 4 mm below the left coronary cusp. We hypothesized that interference between the capsule tip and the calcified nodule on the NCC leaflet inhibited the re-sheathing process.</p><p><strong>Conclusion: </strong>This report documents a rare complication involving the failure to recapture the Navitor valve. In cases with large calcified nodules on the leaflet, caution is essential during the re-sheathing process. We strongly recommend re-deploying the prosthesis rather than attempting to remove it from the basal ring to minimize procedural risks and ensure proper valve placement.</p>\",\"PeriodicalId\":11910,\"journal\":{\"name\":\"European Heart Journal: Case Reports\",\"volume\":\"9 1\",\"pages\":\"ytaf015\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770386/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Heart Journal: Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/ehjcr/ytaf015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjcr/ytaf015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:经导管主动脉瓣植入术(TAVI)中使用的自膨胀瓣膜旨在允许重新捕获和重新定位,促进最佳放置,减轻传导干扰和瓣旁渗漏。在这里,我们提出一个罕见的病例,Navitor (Abbott Structural Heart, Santa Clara, CA, USA)不能被重新捕获。病例总结:一名81岁的日本女性,患有非常严重的主动脉狭窄和非冠状动脉尖处的大量钙化结节(NCC),接受了25毫米Navitor瓣膜的TAVI手术。在初始部署过程中,当阀门部署到80%时,在NCC侧观察到非均匀膨胀(NUE)。我们尝试重新捕获和重新定位瓣膜,但输送系统胶囊未能完全重新包裹假体,导致大约三分之一的瓣膜在胶囊外,无法完全重新捕获。导航器在仍在基环内时被迅速重新部署。重新部署后,NUE得以解决,瓣膜成功定位于NCC侧基环下3mm和左冠状动脉尖下4mm处。我们假设囊尖端和NCC小叶上钙化结节之间的干扰抑制了重新鞘鞘的过程。结论:本报告记录了一例罕见的并发症,涉及到Navitor瓣膜复位失败。在小叶上有大钙化结节的病例中,在重鞘过程中必须谨慎。我们强烈建议重新放置假体,而不是试图将其从基环移除,以尽量减少手术风险并确保正确的瓣膜放置。
Re-sheathing failure with Navitor during transcatheter aortic valve implantation: a case report.
Background: Self-expanding valves used in transcatheter aortic valve implantation (TAVI) are designed to allow recapture and repositioning, facilitating optimal placement and mitigating conduction disturbances and paravalvular leakage. Here, we present a rare case in which the Navitor (Abbott Structural Heart, Santa Clara, CA, USA) could not be recaptured.
Case summary: An 81-year-old Japanese woman with very severe aortic stenosis and a massively calcified nodule at the non-coronary cusp (NCC) underwent TAVI with a 25 mm Navitor valve. During the initial deployment attempt, non-uniform expansion (NUE) was observed on the NCC side when the valve was 80% deployed. An attempt was made to recapture and reposition the valve, but the delivery system capsule failed to fully re-sheath the prosthesis, leaving approximately one-third of the valve outside the capsule and preventing complete recapture. The Navitor was promptly redeployed while still within the basal ring. Following redeployment, the NUE resolved, and the valve was successfully positioned 3 mm below the basal ring on the NCC side and 4 mm below the left coronary cusp. We hypothesized that interference between the capsule tip and the calcified nodule on the NCC leaflet inhibited the re-sheathing process.
Conclusion: This report documents a rare complication involving the failure to recapture the Navitor valve. In cases with large calcified nodules on the leaflet, caution is essential during the re-sheathing process. We strongly recommend re-deploying the prosthesis rather than attempting to remove it from the basal ring to minimize procedural risks and ensure proper valve placement.